alanine has been researched along with etoposide in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campain, JA; Gottesman, MM; Pastan, I | 1 |
| Carr, B; Deng, X; Ito, T; May, WS | 1 |
| Komano, T; Morishima, M; Taguchi, Y; Ueda, K | 1 |
| Chen, Q; Yang, Y; Zhang, JT | 1 |
| Bender, RP; Osheroff, N | 1 |
| Klamt, F; Levine, RL; Pariser, A; Shacter, E; Veenstra, TD; Yu, LR; Zdanov, S; Zhang, B; Zhang, Y | 1 |
| Mizutani, S; Porter, AC; Sato, M; Shimizu, T; Takagi, M; Tamaichi, H | 1 |
| Al-Rawi, J; Bradley, C; Fitzgibbon, C; Ihmaid, S; Meehan-Andrews, T | 1 |
| Adamski, J; Halama, A; Hrabě de Angelis, M; Möller, G; Riesen, N | 1 |
9 other study(ies) available for alanine and etoposide
| Article | Year |
|---|---|
A novel mutant topoisomerase II alpha present in VP-16-resistant human melanoma cell lines has a deletion of alanine 429.
Topics: Alanine; Alleles; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Line; DNA Primers; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Etoposide; HeLa Cells; Humans; Melanoma; Molecular Sequence Data; Polymerase Chain Reaction; Restriction Mapping; Sequence Deletion; Tumor Cells, Cultured | 1994 |
Bcl-2 phosphorylation required for anti-apoptosis function.
Topics: Alanine; Animals; Apoptosis; Bryostatins; Cell Line; Dimerization; Enzyme Activation; Etoposide; Glutamic Acid; Interleukin-3; Kinetics; Lactones; Macrolides; Mice; Mutagenesis, Site-Directed; Phosphates; Phosphorylation; Point Mutation; Protein Kinase C; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Serine; Transfection | 1997 |
Amino acid substitutions in the first transmembrane domain (TM1) of P-glycoprotein that alter substrate specificity.
Topics: Alanine; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Cells, Cultured; Colchicine; DNA Mutational Analysis; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Etoposide; Glycine; Histidine; Humans; Immunoblotting; Isoleucine; Leucine; Substrate Specificity; Vinblastine | 1997 |
Structural and functional consequences of mutating cysteine residues in the amino terminus of human multidrug resistance-associated protein 1.
Topics: Adenosine Triphosphate; Alanine; Amino Acid Sequence; Antineoplastic Agents; Blotting, Western; Cell Membrane; Cell Separation; Cells, Cultured; Colchicine; Cysteine; DNA Mutational Analysis; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Glycosylation; Humans; Kinetics; Leukotriene C4; Microscopy, Confocal; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutation; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Structure-Activity Relationship; Time Factors; Transfection; Trypsin; Vincristine | 2002 |
Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
Topics: Alanine; Amino Acid Substitution; Antigens, Neoplasm; Benzoquinones; Cysteine; DNA Cleavage; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Superhelical; Etoposide; Humans; Kinetics; Mass Spectrometry; Models, Molecular; Mutant Proteins; Mutation; Protein Structure, Tertiary; Quinones; Recombinant Proteins; Temperature | 2007 |
Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin.
Topics: Alanine; Amino Acid Substitution; Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Chlorocebus aethiops; Cofilin 1; COS Cells; Cysteine; Cytochrome c Group; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fibroblasts; Humans; Hydrogen Peroxide; Mitochondria, Liver; Oxidants; Oxidation-Reduction; Plasmids; Rats; Recombinant Proteins; RNA, Small Interfering; Subcellular Fractions; Taurine; Time Factors; Transfection | 2009 |
Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor.
Topics: Alanine; Antigens, Neoplasm; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Histone-Lysine N-Methyltransferase; Humans; Leukemia; Mutagenesis, Site-Directed; Myeloid-Lymphoid Leukemia Protein; Phosphorylation; Poly-ADP-Ribose Binding Proteins; Protein Serine-Threonine Kinases; Serine; Topoisomerase II Inhibitors; Tumor Suppressor Proteins | 2013 |
Chemo-sensitisation of HeLa cells to etoposide by a benzoxazine in the absence of DNA-PK inhibition.
Topics: Alanine; Antineoplastic Agents; Apoptosis; Benzoxazines; Cell Cycle; Cell Proliferation; Cell Survival; DNA-Activated Protein Kinase; Etoposide; HeLa Cells; Histones; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Topoisomerase II Inhibitors | 2013 |
Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine.
Topics: Alanine; Amino Acids; Apoptosis; Biomarkers; Carnitine; Caspase 3; Caspase 7; Cell Line, Tumor; Etoposide; Flow Injection Analysis; Fluorouracil; Glutamic Acid; HEK293 Cells; Hep G2 Cells; Humans; Metabolomics; Precision Medicine | 2013 |